IL234116B - A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system - Google Patents

A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system

Info

Publication number
IL234116B
IL234116B IL234116A IL23411614A IL234116B IL 234116 B IL234116 B IL 234116B IL 234116 A IL234116 A IL 234116A IL 23411614 A IL23411614 A IL 23411614A IL 234116 B IL234116 B IL 234116B
Authority
IL
Israel
Prior art keywords
treatment
composition
parainfluenza virus
sialidase activity
immunocomprimised
Prior art date
Application number
IL234116A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ansun Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ansun Biopharma Inc filed Critical Ansun Biopharma Inc
Publication of IL234116B publication Critical patent/IL234116B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL234116A 2012-02-17 2014-08-13 A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system IL234116B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261600545P 2012-02-17 2012-02-17
US201261727627P 2012-11-16 2012-11-16
PCT/US2013/026754 WO2013123521A1 (en) 2012-02-17 2013-02-19 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients

Publications (1)

Publication Number Publication Date
IL234116B true IL234116B (en) 2020-03-31

Family

ID=48984833

Family Applications (2)

Application Number Title Priority Date Filing Date
IL234116A IL234116B (en) 2012-02-17 2014-08-13 A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system
IL273194A IL273194B2 (en) 2012-02-17 2020-03-10 Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL273194A IL273194B2 (en) 2012-02-17 2020-03-10 Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients

Country Status (9)

Country Link
US (4) US20130280332A1 (OSRAM)
EP (1) EP2841092B1 (OSRAM)
JP (1) JP2015508780A (OSRAM)
CN (2) CN109529026A (OSRAM)
AU (3) AU2013221230A1 (OSRAM)
CA (1) CA2864746A1 (OSRAM)
ES (1) ES2970401T3 (OSRAM)
IL (2) IL234116B (OSRAM)
WO (1) WO2013123521A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799403C (en) 2010-05-14 2020-01-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
US8981083B2 (en) 2010-05-14 2015-03-17 Dana Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
EP3024327B1 (en) 2013-07-25 2019-09-04 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
WO2015070020A2 (en) 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
RU2016134947A (ru) 2014-01-31 2018-03-01 Дана-Фарбер Кансер Институт, Инк. Производные диаминопиримидин бензолсульфона и их применение
RU2722179C2 (ru) 2014-02-28 2020-05-28 Тэнша Терапеутикс, Инк. Лечение состояний, ассоциированных с гиперинсулинемией
JP2017525759A (ja) 2014-08-08 2017-09-07 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジヒドロプテリジノン誘導体およびその使用
CA2955074A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
EP3212654B1 (en) 2014-10-27 2020-04-08 Tensha Therapeutics, Inc. Bromodomain inhibitors
CA2966336A1 (en) * 2014-11-06 2016-05-12 Dana-Farber Cancer Institute, Inc. Use of compositions modulating chromatin structure for graft versus host disease (gvhd)
US11236082B2 (en) 2014-11-06 2022-02-01 Dana-Farber Cancer Institute, Inc. EZH2 inhibitors and uses thereof
WO2016200916A1 (en) * 2015-06-08 2016-12-15 Ansun Biopharma, Inc. Treatment of human metapneumovirus
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CA2996977A1 (en) 2015-09-11 2017-03-16 Dana-Farber Cancer Institute, Inc. Acetamide thienotriazolodiazepines and uses thereof
BR112018004618A2 (pt) 2015-09-11 2018-09-25 Dana-Farber Cancer Institute, Inc. ciano tienotriazoldiazepinas e usos das mesmas
US10913752B2 (en) 2015-11-25 2021-02-09 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof
WO2017184999A1 (en) 2016-04-22 2017-10-26 Dana-Farber Cancer Institute, Inc. Ezh2 inhibitors and uses thereof
KR20220151601A (ko) * 2019-11-25 2022-11-15 안선 바이오파르마, 아이엔씨. 암세포, 면역세포 및 종양 미세환경으로의 시알리다제의 면역세포 전달

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7040314B2 (en) * 2002-09-06 2006-05-09 Philip Morris Usa Inc. Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
CN101804200A (zh) 2002-11-22 2010-08-18 余芒 广谱抗病毒的治疗和预防
US20070190163A1 (en) * 2006-01-24 2007-08-16 Malaknov Michael P Technology for preparation of macromolecular microspheres
CA2780193A1 (en) * 2009-11-06 2011-05-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract

Also Published As

Publication number Publication date
US20150132274A1 (en) 2015-05-14
EP2841092C0 (en) 2023-12-06
ES2970401T3 (es) 2024-05-28
EP2841092B1 (en) 2023-12-06
HK1207975A1 (en) 2016-02-19
JP2015508780A (ja) 2015-03-23
AU2019226190B2 (en) 2021-10-07
WO2013123521A1 (en) 2013-08-22
CN109529026A (zh) 2019-03-29
IL273194A (en) 2020-04-30
CA2864746A1 (en) 2013-08-22
US20210046165A1 (en) 2021-02-18
EP2841092A4 (en) 2015-09-16
EP2841092A1 (en) 2015-03-04
AU2017258955A1 (en) 2017-12-14
IL273194B2 (en) 2023-02-01
AU2013221230A1 (en) 2014-10-02
IL273194B (en) 2022-10-01
AU2019226190A1 (en) 2019-09-26
US20130280332A1 (en) 2013-10-24
CN104203267A (zh) 2014-12-10
US20170151315A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
IL234116B (en) A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system
IL249991A0 (en) Methods of treating sick children by dexmedetomidine
ZA201308417B (en) Tissue healing
IL234678A0 (en) Diagnostic methods and preparations for cancer treatment
EP2675478A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF GRIP
IL237568A0 (en) Assembly for the treatment of biological tissues
GB201202773D0 (en) Compositions for treatment of skin disorders
HUE038787T2 (hu) Tripeptid készítmények és alkalmazásuk diabétesz kezelésére
EP2797593A4 (en) SILICONE-BASED COMPOSITION FOR TREATING SKIN
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
IL232434A0 (en) Medicine for medical treatment and/or improvement of sepsis
EP2872087A4 (en) IMPROVED NON-SKINLESSING DISPOSABLE THREAD
GB201102248D0 (en) Treatment of bipolar disorder
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
ZA201408065B (en) Compositions and methods for the treatment of diabetes
SG11201504201RA (en) Purification of x-ray contrast agents
ZA201409502B (en) Composition for treatment of warts
GB201010638D0 (en) Composition for treatment of skin
PT2456445E (pt) Agente para o tratamento de condições da pele
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
GB201110653D0 (en) Composition for skin treatment
GB201110659D0 (en) composition for skin treatment
GB201208505D0 (en) Treatment of skin condition
GB201121044D0 (en) Treatment of solutions
GB201104632D0 (en) Use of medicament

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed